NFSG
RCKT icon

Newbridge Financial Services Group’s Rocket Pharmaceuticals RCKT Stock Holding History

Newbridge Financial Services Group’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-18
Closed -$369 – 1298
2023
Q3 		$369 Hold
18
– – ﹤0.01% 1218
2023
Q2 		$358 Hold
18
– – ﹤0.01% 1271
2023
Q1 		$308 Hold
18
– – ﹤0.01% 1340
2022
Q4 		$352 Hold
18
– – ﹤0.01% 1370
2022
Q3 		$0 Hold
18
– – ﹤0.01% 1462
2022
Q2 		$0 Hold
18
– – ﹤0.01% 1490
2022
Q1 		$0 Hold
18
– – ﹤0.01% 1539
2021
Q4 		$0 Hold
18
– – ﹤0.01% 1519
2021
Q3 		$1K Hold
18
– – ﹤0.01% 1299
2021
Q2 		$1K Hold
18
– – ﹤0.01% 1384
2021
Q1 		$1K Buy
+18
New +$988 ﹤0.01% 1312

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return